New positions 2
| Company | Value | % of portfolio |
|---|---|---|
| TE Connectivity TEL | $228.2M | 3.7% |
| Ferguson Enterprises FERG | $145.9M | 2.4% |
Institutional investment manager (13F filer) CIK 1426092Its filings on EDGARAll funds
Measures activity, not value. Not investment advice.
Reported $6.2B in 24 companies we cover at the end of Q3 2026; opened 2 positions and sold out of 0; largest new position: TE Connectivity, $228.2M.
Q4 2016Highest $23.9BQ3 2026
| Quarter | Reported value | Positions we cover | Filed | Report |
|---|---|---|---|---|
| Q3 2026 | $6.2B | 24 | 13 Nov 2026 | 13F-HR |
| Q2 2026 | $6.2B | 22 | 13 Aug 2026 | 13F-HR |
| Q1 2026 | $7.1B | 24 | 15 May 2026 | 13F-HR |
| Q4 2025 | $9.6B | 23 | 17 Feb 2026 | 13F-HR |
| Q3 2025 | $9.6B | 23 | 13 Nov 2025 | 13F-HR |
| Q2 2025 | $11.6B | 24 | 13 Aug 2025 | 13F-HR |
| Q1 2025 | $12.4B | 25 | 14 May 2025 | 13F-HR |
| Q4 2024 | $13.4B | 24 | 13 Feb 2025 | 13F-HR |
| Q3 2024 | $14.6B | 24 | 13 Nov 2024 | 13F-HR |
| Q2 2024 | $13.5B | 24 | 13 Aug 2024 | 13F-HR |
| Q1 2024 | $15.5B | 24 | 14 May 2024 | 13F-HR |
| Q4 2023 | $15.0B | 25 | 13 Feb 2024 | 13F-HR |
| Q3 2023 | $14.1B | 25 | 13 Nov 2023 | 13F-HR |
| Q2 2023 | $15.3B | 26 | 11 Aug 2023 | 13F-HR |
| Q1 2023 | $14.2B | 25 | 12 May 2023 | 13F-HR |
| Q4 2022 | $12.6B | 26 | 13 Feb 2023 | 13F-HR |
| Q3 2022 | $11.7B | 27 | 14 Nov 2022 | 13F-HR |
| Q2 2022 | $13.1B | 25 | 12 Aug 2022 | 13F-HR |
| Q1 2022 | $15.3B | 26 | 13 May 2022 | 13F-HR |
| Q4 2021 | $15.7B | 25 | 11 Feb 2022 | 13F-HR |
| Q3 2021 | $15.9B | 24 | 12 Nov 2021 | 13F-HR |
| Q2 2021 | $18.2B | 25 | 13 Aug 2021 | 13F-HR |
| Q1 2021 | $18.8B | 26 | 14 May 2021 | 13F-HR |
| Q4 2020 | $20.6B | 25 | 16 Feb 2021 | 13F-HR |
| Q3 2020 | $21.3B | 24 | 13 Nov 2020 | 13F-HR |
| Q2 2020 | $21.1B | 26 | 14 Aug 2020 | 13F-HR |
| Q1 2020 | $18.6B | 24 | 14 May 2020 | 13F-HR |
| Q4 2019 | $23.9B | 23 | 13 Feb 2020 | 13F-HR |
| Q3 2019 | $21.5B | 22 | 13 Nov 2019 | 13F-HR |
| Q2 2019 | $20.6B | 21 | 13 Aug 2019 | 13F-HR |
| Q1 2019 | $19.0B | 24 | 15 May 2019 | 13F-HR |
| Q4 2018 | $18.8B | 26 | 13 Feb 2019 | 13F-HR |
| Q3 2018 | $20.3B | 25 | 19 Oct 2018 | 13F-HR |
| Q2 2018 | $19.2B | 24 | 1 Aug 2018 | 13F-HR |
| Q1 2018 | $19.1B | 24 | 16 Apr 2018 | 13F-HR |
| Q4 2017 | $19.1B | 22 | 6 Feb 2018 | 13F-HR |
| Q3 2017 | $18.5B | 23 | 30 Oct 2017 | 13F-HR |
| Q2 2017 | $17.3B | 26 | 26 Jul 2017 | 13F-HR |
| Q1 2017 | $15.4B | 25 | 8 May 2017 | 13F-HR |
| Q4 2016 | $15.1B | 25 | 10 Feb 2017 | 13F-HR |
| Q3 2016 | $15.4B | 22 | 7 Nov 2016 | 13F-HR |
| Q2 2016 | $15.0B | 22 | 29 Jul 2016 | 13F-HR |
| Q1 2016 | $15.0B | 21 | 20 Apr 2016 | 13F-HR |
| Q4 2015 | $14.7B | 22 | 29 Jan 2016 | 13F-HR |
| Q3 2015 | $14.2B | 22 | 2 Nov 2015 | 13F-HR |
| Q2 2015 | $15.2B | 20 | 3 Aug 2015amended 18 Sep 2015 | 13F-HR/A |
| Q1 2015 | $14.4B | 19 | 7 May 2015amended 18 Sep 2015 | 13F-HR/A |
| Q4 2014 | $13.6B | 18 | 6 Feb 2015 | 13F-HR |
| Q3 2014 | $12.6B | 17 | 6 Nov 2014amended 25 Feb 2015 | 13F-HR/A |
| Q2 2014 | $12.6B | 16 | 1 Aug 2014amended 25 Feb 2015 | 13F-HR/A |
| Q1 2014 | $12.9B | 16 | 1 May 2014amended 25 Feb 2015 | 13F-HR/A |
| Q4 2013 | $12.1B | 13 | 4 Feb 2014amended 25 Feb 2015 | 13F-HR/A |
| Q3 2013 | $10.8B | 15 | 8 Nov 2013amended 25 Feb 2015 | 13F-HR/A |
| Q2 2013 | $10.1B | 15 | 5 Aug 2013 | 13F-HR |
| # | Company | Shares | Value | % of portfolio The position's value as a share of the reported value of the whole report. | % of company Shares held as a share of the company's shares outstanding (latest financial report). | Change vs Q2 2026 |
|---|---|---|---|---|---|---|
| 1 | West Pharmaceutical Services WST | 927K | $343.9M | 5.6% | 1.3% | -106K-10% |
| 2 | Thermo Fisher Scientific TMO | 506K | $341.9M | 5.6% | 0.14% | -23K-4.4% |
| 3 | IQVIA IQV | 1.3M | $337.8M | 5.5% | 0.76% | -244K-16% |
| 4 | Microsoft MSFT | 622K | $319.0M | 5.2% | 0.01% | -23K-3.6% |
| 5 | Unitedhealth UNH | 807K | $296.2M | 4.8% | 0.09% | -36K-4.2% |
| 6 | Becton, Dickinson and BDX | 1.6M | $290.0M | 4.7% | 0.59% | -70K-4.2% |
| 7 | Texas Instruments TXN | 1.0M | $289.9M | 4.7% | 0.11% | -46K-4.3% |
| 8 | VISA V | 783K | $281.2M | 4.6% | -35K-4.3% | |
| 9 | Alphabet GOOGL | 792K | $272.4M | 4.4% | -36K-4.3% | |
| 10 | Salesforce CRM | 1.1M | $262.1M | 4.3% | 0.14% | -51K-4.3% |
| 11 | CME CME | 972K | $254.7M | 4.1% | -29K-2.9% | |
| 12 | American Express AXP | 813K | $247.4M | 4.0% | 0.12% | -36K-4.2% |
| 13 | Moody's MCO | 535K | $243.0M | 3.9% | 0.31% | -24K-4.2% |
| 14 | Progressive PGR | 1.2M | $242.0M | 3.9% | 0.20% | -52K-4.3% |
| 15 | MSCI MSCI | 444K | $239.2M | 3.9% | 0.62% | -20K-4.3% |
| 16 | Sysco SYY | 3.0M | $230.3M | 3.7% | 0.60% | -132K-4.3% |
| 17 | Booking BKNG | 1.4M | $229.6M | 3.7% | 0.19% | -64K-4.3% |
| 18 | CDW CDW | 1.8M | $229.4M | 3.7% | 1.4% | -78K-4.2% |
| 19 | TE Connectivity TEL | 1.1M | $228.2M | 3.7% | 0.38% | New |
| 20 | Aon AON | 736K | $203.7M | 3.3% | 0.35% | -33K-4.3% |
| 21 | Fidelity National Information Services FIS | 6.0M | $198.3M | 3.2% | 1.2% | -256K-4.1% |
| 22 | Ferguson Enterprises FERG | 655K | $145.9M | 2.4% | 0.34% | New |
| 23 | S&P Global SPGI | 256K | $100.9M | 1.6% | 0.09% | -11K-4.3% |
| 24 | Cooper Companies COO | 371K | $21.0M | 0.34% | 0.19% | -3.6M-91% |
| Company | Value | % of portfolio |
|---|---|---|
| TE Connectivity TEL | $228.2M | 3.7% |
| Ferguson Enterprises FERG | $145.9M | 2.4% |
None.
None.
| Company | Cut | Shares |
|---|---|---|
| Cooper Companies COO | -$201.8M | -3.6M-91% |
| IQVIA IQV | -$65.7M | -244K-16% |
| West Pharmaceutical Services WST | -$39.4M | -106K-10% |
| Thermo Fisher Scientific TMO | -$15.7M | -23K-4.4% |
| Unitedhealth UNH | -$13.1M | -36K-4.2% |
| Texas Instruments TXN | -$12.9M | -46K-4.3% |
| VISA V | -$12.6M | -35K-4.3% |
| Becton, Dickinson and BDX | -$12.6M | -70K-4.2% |
| Alphabet GOOGL | -$12.2M | -36K-4.3% |
| Microsoft MSFT | -$12.0M | -23K-3.6% |
| Salesforce CRM | -$11.8M | -51K-4.3% |
| American Express AXP | -$10.9M | -36K-4.2% |
| Progressive PGR | -$10.8M | -52K-4.3% |
| Moody's MCO | -$10.7M | -24K-4.2% |
| MSCI MSCI | -$10.6M | -20K-4.3% |
| Sector | Q3 2026 | As a bar | Q2 2026 | Change |
|---|---|---|---|---|
| Technology | 25% | 23% | +2.9 pts | |
| Financials | 21% | 24% | -2.4 pts | |
| Services | 18% | 20% | -1.5 pts | |
| Health Care | 17% | 21% | -3.6 pts | |
| Wholesale Trade | 10% | 4.4% | +5.9 pts | |
| Transportation | 3.9% | 4.5% | -0.6 pts | |
| Retail | 3.9% | 4.5% | -0.6 pts |
The bar is Q3 2026; the tick marks Q2 2026.
From Form 13F: long positions in US-listed shares and options at the quarter end, filed up to 45 days later; short positions are not reported. Values are in dollars (reports filed before 2023 were in thousands and are converted). Measures activity, not value. Not investment advice.